THE EFFECT OF ANTI-PD-1 THERAPY ON MEDIAN OVERALL SURVIVAL AND PROGRESSION FREE SURVIVAL IN GLIOBLASTOMA MULTIFORME PATIENTS WITH CERTAIN TUMOR MARKERS

被引：1
|
作者：
Paracha, Awais [1 ]
Campian, Jian [2 ]
机构：
[1] St Louis Univ, Sch Med, St Louis, MO USA
[2] Washington Univ, St Louis, MO 63110 USA
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2020年 / 8卷
关键词：
D O I：
10.1136/jitc-2020-SITC2020.0214
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
214
引用
收藏
页码：A128 / A128
页数：1
相关论文
共 50 条
  • [1] Effect of Zinc Sulfate on Overall Survival and Progression-Free Survival in Patients with Glioblastoma Multiforme, a Phase II Study
    Ahmadloo, Niloofar
    Kameli, Parisa
    Ansari, Mansour
    Mosalaei, Ahmad
    Omidvari, Shapour
    Nasrollahi, Hamid
    Hamedi, Seyed Hassan
    Mohammadianpanah, Mohammad
    MIDDLE EAST JOURNAL OF CANCER, 2023, 14 (01) : 113 - 118
  • [2] Relationship between overall survival and progression-free survival for recent NCCTG glioblastoma multiforme trials
    Wu, Wenting
    Galanis, Evanthia
    Buckner, Jan C.
    Jaeckle, Kurt A.
    Sargent, Daniel J.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [3] TUMOR-INFILTRATING LYMPHOCYTES EXPRESSING ANTI-PD-1 ANTIBODY EXHIBIT A PROMISING EFFICACY AND SURVIVAL BENEFIT IN PATIENTS WITH RECURRENT GLIOBLASTOMA MULTIFORME
    Tang, Chao
    Zhang, Zhi
    Chen, Di
    Ji, Kai
    Ji, Chunxia
    Liu, Xiao
    Chen, Ling
    Lu, Qiqi
    Chu, Wen
    Qin, Wen
    Xu, Fei
    Jin, Hua
    Qian, Qi
    Yao, Yu
    Zhou, Liang
    NEURO-ONCOLOGY, 2019, 21 : 3 - 4
  • [4] Overall responses and survival in RCC on pegilodecakin with anti-PD-1
    Naing, A.
    Infante, J. R.
    Wong, D. J.
    Korn, W. M.
    Aljumaily, R.
    Papadopoulos, K. P.
    Autio, K. A.
    Pant, S.
    Bauer, T. M.
    Drakaki, A.
    Daver, N. G.
    Hung, A.
    Verma, R.
    Ratti, N.
    McCauley, S.
    Van Vlasselaer, P.
    Tannir, M.
    Oft, M.
    EUROPEAN JOURNAL OF CANCER, 2019, 110 : S1 - S2
  • [5] Does dose to subventricular zone act as a predictor of overall survival and progression free survival in glioblastoma multiforme (GBM)?
    Lall, N.
    Choudhary, S.
    Aggrawal, L.
    Kumar, A.
    ANNALS OF ONCOLOGY, 2024, 35 : S1687 - S1688
  • [6] Seasonal variation in effect of anti-PD-1 initiation on overall survival among patients with advanced melanoma
    Ellebaek, Eva
    Schina, Aimilia
    Schmidt, Henrik
    Haslund, Charlotte Aaquist
    Bastholt, Lars
    Svane, Inge Marie
    Donia, Marco
    PIGMENT CELL & MELANOMA RESEARCH, 2023, 36 (02) : 224 - 231
  • [7] Evaluation of tumor shape features for overall survival prognosis in glioblastoma multiforme patients
    Sanghani, Parita
    Ti, Ang Beng
    King, Nicolas Kon Kam
    Ren, Hongliang
    SURGICAL ONCOLOGY-OXFORD, 2019, 29 : 178 - 183
  • [8] Thyroid dysfunction induced by anti-PD-1 therapy is associated with a better progression-free survival in patients with advanced carcinoma
    Yiran Lu
    Qingchen Li
    Lusi Xu
    Yanqing Zheng
    Yanchao Wang
    Ying Liu
    Rui Zhang
    Lin Liao
    Jianjun Dong
    Journal of Cancer Research and Clinical Oncology, 2023, 149 : 16501 - 16510
  • [9] Thyroid dysfunction induced by anti-PD-1 therapy is associated with a better progression-free survival in patients with advanced carcinoma
    Lu, Yiran
    Li, Qingchen
    Xu, Lusi
    Zheng, Yanqing
    Wang, Yanchao
    Liu, Ying
    Zhang, Rui
    Liao, Lin
    Dong, Jianjun
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (18) : 16501 - 16510
  • [10] PROGNOSTIC FACTORS FOR OVERALL SURVIVAL IN PATIENTS WITH ADVANCED MELANOMA TREATED WITH ANTI-PD-1 THERAPY - THE MELIMMUNE SCORE
    Lobo-Martins, Soraia
    Martins-Branco, Diogo
    Semedo, Patricia Miguel
    Alvim, Cecilia Melo
    Monteiro, Ana Maria
    Vendrell, Ines
    Gouveia, Emanuel
    Passos, Maria Jose
    Costa, Luis
    Mansinho, Andre
    de Sousa, Rita Teixeira
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A4 - A4
12345